688073 毕得医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.1035.26110.79319.65023.580
总资产报酬率 ROA (%)3.5184.5908.94113.80315.262
投入资产回报率 ROIC (%)3.8815.06210.38018.35521.331

边际利润分析
销售毛利率 (%)41.17340.00044.37849.45954.376
营业利润率 (%)12.60711.59820.59618.91218.092
息税前利润/营业总收入 (%)11.9638.83318.45719.72520.412
净利润/营业总收入 (%)10.3359.93217.50616.09515.073

收益指标分析
经营活动净收益/利润总额(%)111.757120.092100.850100.307110.061
价值变动净收益/利润总额(%)2.714-7.042-0.2350.3560.712
营业外收支净额/利润总额(%)0.102-0.5020.022-0.075-0.785

偿债能力分析
流动比率 (X)6.8378.2239.0123.2773.191
速动比率 (X)4.5915.6806.9171.3671.665
资产负债率 (%)15.05813.47811.99830.59928.250
带息债务/全部投入资本 (%)4.5592.1771.4472.1987.047
股东权益/带息债务 (%)2,054.3644,387.9926,700.5924,261.8661,318.990
股东权益/负债合计 (%)564.092641.976733.488226.804253.980
利息保障倍数 (X)-18.225-3.263-8.61023.8368.296

营运能力分析
应收账款周转天数 (天)77.25567.92765.12962.24063.137
存货周转天数 (天)398.613335.560387.482408.530352.104